Cargando…

Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center

OBJECTIVES: Mixed connective tissue disease is a rare systemic connective tissue disease of developmental age and it includes the features of arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus and systemic sclerosis, with presence of anti-ribonucleoprotein antibodies (anti-RNP) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowska-Sak, Lidia, Gietka, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091480/
https://www.ncbi.nlm.nih.gov/pubmed/32226164
http://dx.doi.org/10.5114/reum.2019.91275
_version_ 1783510017596456960
author Rutkowska-Sak, Lidia
Gietka, Piotr
author_facet Rutkowska-Sak, Lidia
Gietka, Piotr
author_sort Rutkowska-Sak, Lidia
collection PubMed
description OBJECTIVES: Mixed connective tissue disease is a rare systemic connective tissue disease of developmental age and it includes the features of arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus and systemic sclerosis, with presence of anti-ribonucleoprotein antibodies (anti-RNP) in serum. Early diagnosis of the disease is difficult but essential in preventing development of systemic complications, which are often irreversible. International literature does not report many studies on large cohorts of children with this disease. The aim of this retrospective study was to define clinical characteristics and long-term results of treatment of the disease in 60 children with mixed connective tissue disease hospitalized in the period between 1978 and 2018. The diagnosis was established on the basis of Kasukawa’s criteria. MATERIAL AND METHODS: It was a group of 60 children (46 girls and 16 boys) aged 10.5 on average (4–16.5). When assessing general symptoms at the onset of the disease according to Kasukawa’s criteria, the highest number, over 80% of children, demonstrated symptoms suggesting SLE, about 40% suggesting DM and about 25% suggesting SSC. In the period of observation the number of children with clinical symptoms suggesting SSC increased. The most common clinical symptoms included Raynaud syndrome, arthritis and myositis and the most common irregularities in the test results included presence of anti-RNP antibodies and rheumatoid factor and hematological symptoms such as leukopenia/thrombocytopenia. Restrictive lung function impairment was demonstrated by 20% of children. Treatment most often included combined therapy (glucocorticosteroids + methotrexate/azathioprine). RESULTS: In 70% of the patients stable improvement was observed. Remission concerned 7% of the patients, frequent exacerbations were found in almost 20% of patients, and 2 children (3.5%) died. CONCLUSIONS: The long term observations of patients in developementeal age with mixed connective tissue disease revealed that the majority of them had domination of SLE symptoms, only in 7% achieved remission and 70% remained in stable improvement. Serious infections with septic state were the cause of death in two cases.
format Online
Article
Text
id pubmed-7091480
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
record_format MEDLINE/PubMed
spelling pubmed-70914802020-03-27 Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center Rutkowska-Sak, Lidia Gietka, Piotr Reumatologia Original Paper OBJECTIVES: Mixed connective tissue disease is a rare systemic connective tissue disease of developmental age and it includes the features of arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus and systemic sclerosis, with presence of anti-ribonucleoprotein antibodies (anti-RNP) in serum. Early diagnosis of the disease is difficult but essential in preventing development of systemic complications, which are often irreversible. International literature does not report many studies on large cohorts of children with this disease. The aim of this retrospective study was to define clinical characteristics and long-term results of treatment of the disease in 60 children with mixed connective tissue disease hospitalized in the period between 1978 and 2018. The diagnosis was established on the basis of Kasukawa’s criteria. MATERIAL AND METHODS: It was a group of 60 children (46 girls and 16 boys) aged 10.5 on average (4–16.5). When assessing general symptoms at the onset of the disease according to Kasukawa’s criteria, the highest number, over 80% of children, demonstrated symptoms suggesting SLE, about 40% suggesting DM and about 25% suggesting SSC. In the period of observation the number of children with clinical symptoms suggesting SSC increased. The most common clinical symptoms included Raynaud syndrome, arthritis and myositis and the most common irregularities in the test results included presence of anti-RNP antibodies and rheumatoid factor and hematological symptoms such as leukopenia/thrombocytopenia. Restrictive lung function impairment was demonstrated by 20% of children. Treatment most often included combined therapy (glucocorticosteroids + methotrexate/azathioprine). RESULTS: In 70% of the patients stable improvement was observed. Remission concerned 7% of the patients, frequent exacerbations were found in almost 20% of patients, and 2 children (3.5%) died. CONCLUSIONS: The long term observations of patients in developementeal age with mixed connective tissue disease revealed that the majority of them had domination of SLE symptoms, only in 7% achieved remission and 70% remained in stable improvement. Serious infections with septic state were the cause of death in two cases. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019-12-31 2019 /pmc/articles/PMC7091480/ /pubmed/32226164 http://dx.doi.org/10.5114/reum.2019.91275 Text en Copyright: © 2019 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Rutkowska-Sak, Lidia
Gietka, Piotr
Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title_full Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title_fullStr Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title_full_unstemmed Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title_short Clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
title_sort clinical features and outcome of mixed connective tissue disease in developmental age – observational study from one center
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091480/
https://www.ncbi.nlm.nih.gov/pubmed/32226164
http://dx.doi.org/10.5114/reum.2019.91275
work_keys_str_mv AT rutkowskasaklidia clinicalfeaturesandoutcomeofmixedconnectivetissuediseaseindevelopmentalageobservationalstudyfromonecenter
AT gietkapiotr clinicalfeaturesandoutcomeofmixedconnectivetissuediseaseindevelopmentalageobservationalstudyfromonecenter